Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Soleno Therapeutics Inc SLNO

Healthcare Biotechnology
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate, Diazoxide Choline Extended-Release tablets (DCCR), extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), recently completed its Phase 3... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SLNO)

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

GlobeNewswire 9 days ago

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

Soleno Therapeutics to Participate in Upcoming November Investor Conferences

GlobeNewswire October 28, 2024

Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.

GlobeNewswire October 21, 2024

Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome

GlobeNewswire October 8, 2024

Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference

GlobeNewswire September 16, 2024

Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

GlobeNewswire August 27, 2024

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 19, 2024

Soleno Therapeutics Announces Updates to its Board of Directors

GlobeNewswire August 15, 2024
View More News ››

Opinion & Analysis (NDAQ:SLNO)

Rare Diseases Biotech Provides Opportunity

Streetwise Reports March 22, 2019
View More Opinion ››

Bullboard Posts (NDAQ:SLNO)

Soleno Therapeutics, Inc. (NASDAQ:SLNO): A Promising Rare Di

http://beyondspx.com/2024/08/02/soleno-therapeutics-inc-nasdaqslno-a-promising-rare-disease-biotech-with-significant-upside-potential/
MikeTester - August 3, 2024

SLNO....boooom

rthtrh
Iseneschal - September 26, 2023

RE:SLNO...... Cha f'king Ching !!!!!!

Couldn't have called this any better....out close to the H.o.D  ; ) Didn't leave much on the table and now it's $1.45...
Iseneschal - December 19, 2022

SLNO...... Cha f'king Ching !!!!!!

Thank you ....Merry Xmas !
Iseneschal - December 19, 2022

SLNO..... Yeeha !!!!!!!!!!

When ur sure of something.....gotta join em ; )
Iseneschal - December 19, 2022

SLNO ....Dang....I want my $1.20 shares back

This is going to rip again
Iseneschal - December 19, 2022
View more Bullboard ››

Lahontan Gold Corp.

Lahontan Gold Corp.

Lahontan Gold Corp. is a Canada-based mineral exploration company. The Company is engaged in the identification, acquisition, ...
View More »